Empty your bladder  faster than conventional eyelet catheters with Luja male.1 

Luja is a male intermittent catheter that sets a new standard for faster bladder emptying. Empty your bladder faster than conventional eyelet catheters with Luja.1

Micro-holes. Macro Difference.

Luja is the first intermittent catheter with Micro-hole Zone Technology, with 80+ micro-holes instead of the conventional two eyelets.

Luja is 45% faster at emptying the bladder completely compared to conventional eyelet catheters.1

To request samples and find out more about Luja male, please fill out your details below and a Coloplast Team Member will contact you soon.


State/Territory








Please select the continence products you are currently using*:






Sign up for Coloplast Care for Intermittent Catheter Users
Sample consent declaration
From time to time, we at Coloplast would like to let you know about relevant Coloplast products and services; share inspirational stories from other customers; or tell you about forthcoming events via phone, text, email, or post. Our communication to you will be based on the information you provided to us and your preferences and interests, including your heath data. The choice is yours - and as with any of our services, you may opt-out at any time.


1.Luja is 45% faster at emptying the bladder completely compared to conventional eyelet catheters*

Disclaimer: *Tested in a pre-clinical setting (ex vivo). Complete bladder emptying is defined as <10 mL

2.Micro-hole Zone Technology ensures complete bladder emptying in one position

Landauro MH, Jacobsen L, Tentor F, Pedersen T, Rovsing C , Feix do Nascimento O, Kennelly M. New Intermittent Urinary Micro-Hole Zone Catheter Shows Enhanced Performance in Emptying the Bladder: A Randomised, Controlled Crossover Study. J. Clin. Med. 2023, 12, 5266. https://doi.org/10.3390/jcm12165266

Thiruchelvam N, Landauro MH, Biardeau X et al. Improved emptying performance with a new micro‐hole zone catheter in adult male intermittentcatheter users: A comparative multi‐center randomized controlled cross‐over study. Neurourol Urodyn. 2024:1-15 DOI: 10.1002/nau.25383

Close

Free sample - Free shipping

Thank you for your order

Confirmation

View desktop version